Bio-Techne (TECH) Tax Provisions (2009 - 2026)
Bio-Techne's quarterly Tax Provisions came in at $20.2 million in Q1 2026, up 28.64% year-on-year from $15.7 million in Q1 2025, and up 57.95% quarter-over-quarter from $12.8 million in Q4 2025.
Bio-Techne has reported Tax Provisions for 18 years, with the latest figure at $20.2 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 28.64% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $37.6 million (down 47.43% YoY), and the FY2025 full-year result was $25.1 million, down 56.6% from the prior year.
- Tax Provisions for Q1 2026 stood at $20.2 million, up from $12.8 million in the prior quarter.
- The five-year high for Tax Provisions was $42.6 million in Q2 2023, with the low at -$5.2 million in Q2 2025.
- Average Tax Provisions over 5 years is $13.8 million, with a median of $12.0 million recorded in 2024.
- Year-over-year, Tax Provisions soared 18075.0% in 2022 and sank 112.56% in 2025.
- Tracing TECH's Tax Provisions over 5 years: stood at $16.4 million in 2022, then tumbled by 63.94% to $5.9 million in 2023, then soared by 34.85% to $8.0 million in 2024, then surged by 59.97% to $12.8 million in 2025, then jumped by 57.95% to $20.2 million in 2026.
- The last three Tax Provisions figures came in at $20.2 million (Q1 2026), $12.8 million (Q4 2025), and $9.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 20.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.18 Mn |
| Dec 31, 2025 | 12.78 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Jun 30, 2025 | -5.18 Mn |
| Mar 31, 2025 | 15.69 Mn |
| Dec 31, 2024 | 7.99 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 41.23 Mn |
| Mar 31, 2024 | 12.03 Mn |
| Dec 31, 2023 | 5.92 Mn |
| Sep 30, 2023 | -1.44 Mn |
| Jun 30, 2023 | 42.63 Mn |
| Mar 31, 2023 | 9.98 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 13.98 Mn |
| Jun 30, 2022 | 17.14 Mn |
| Mar 31, 2022 | 8.63 Mn |
| Dec 31, 2021 | 14.12 Mn |
| Sep 30, 2021 | -1.60 Mn |
| Jun 30, 2021 | 20.48 Mn |
| Mar 31, 2021 | -48,000.00 |
| Dec 31, 2020 | 10.22 Mn |
| Sep 30, 2020 | 5.94 Mn |
| Jun 30, 2020 | -10.93 Mn |
| Mar 31, 2020 | 10.39 Mn |
| Dec 31, 2019 | 30.70 Mn |
| Sep 30, 2019 | 3.41 Mn |
| Jun 30, 2019 | 6.33 Mn |
| Mar 31, 2019 | 5.22 Mn |
| Dec 31, 2018 | 4.21 Mn |
| Sep 30, 2018 | 183,000.00 |
| Jun 30, 2018 | 14.57 Mn |
| Mar 31, 2018 | 5.24 Mn |
| Dec 31, 2017 | -27.12 Mn |
| Sep 30, 2017 | 7.10 Mn |
| Jun 30, 2017 | 10.24 Mn |
| Mar 31, 2017 | 8.97 Mn |
| Dec 31, 2016 | 7.72 Mn |
| Sep 30, 2016 | 8.94 Mn |
| Jun 30, 2016 | 14.48 Mn |
| Mar 31, 2016 | 12.20 Mn |
| Dec 31, 2015 | 9.52 Mn |
| Sep 30, 2015 | 9.14 Mn |
| Jun 30, 2015 | -23.81 Mn |
| Mar 31, 2015 | 14.47 Mn |
| Dec 31, 2014 | 9.35 Mn |
| Sep 30, 2014 | 10.69 Mn |
| Jun 30, 2014 | 12.63 Mn |
| Mar 31, 2014 | 14.43 Mn |
| Dec 31, 2013 | 11.16 Mn |
| Sep 30, 2013 | 12.23 Mn |
| Jun 30, 2013 | -24.99 Mn |
| Mar 31, 2013 | 11.35 Mn |
| Dec 31, 2012 | 12.08 Mn |
| Sep 30, 2012 | 12.32 Mn |
| Jun 30, 2012 | 13.38 Mn |
| Mar 31, 2012 | 11.45 Mn |
| Dec 31, 2011 | 12.06 Mn |
| Sep 30, 2011 | 12.98 Mn |
| Jun 30, 2011 | 14.64 Mn |
| Mar 31, 2011 | 14.32 Mn |
| Dec 31, 2010 | 11.14 Mn |
| Sep 30, 2010 | 12.58 Mn |
| Jun 30, 2010 | 3.13 Mn |
| Mar 31, 2010 | 9.05 Mn |
| Dec 31, 2009 | 11.98 Mn |
| Sep 30, 2009 | 12.94 Mn |